SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-16-000089
Filing Date
2016-02-26
Accepted
2016-02-26 17:08:08
Documents
1
Period of Report
2016-02-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K 02.26.16 a8-k022616.htm 8-K 21936
  Complete submission text file 0000320017-16-000089.txt   23384
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 161463124
SIC: 8090 Services-Misc Health & Allied Services, NEC